Latest Breaking News On - Rick winningham - Page 1 : comparemela.com

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024

DUBLIN, April 10, 2024 /PRNewswire/ Theravance Biopharma, Inc. today announced it will host a virtual KOL event on Thursday, May 23, 2024 from 10:00 AM to 11:30 AM ET, featuring Horacio.

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q4 2023 Earnings Call Transcript

Theravance Biopharma, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.04.

Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer's Spiriva

Theravance Biopharma: Phase 4 PIFR-2 Study Fails To Meet Primary Endpoint

Theravance Biopharma, Inc. (TBPH) announced results from the Phase 4 PIFR-2 study of YUPELRI inhalation solution, the nebulized long-acting muscarinic antagonist approved in the U.

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2023 Earnings Call Transcript

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Ladies and gentlemen, good afternoon. I’d like to welcome everyone to Theravance Biopharma’s Third Quarter 2023 Conference Call. During the presentation, all participants will be in a listen-only mode. A question-and-answer session will follow the company’s formal remarks. [Operator Instructions] Also, today’s […]